XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Stockholders' equity at beginning of period (in shares) at Dec. 31, 2021   58,010    
Stockholder's equity at beginning of period at Dec. 31, 2021 $ 268,677 $ 291 $ 395,850 $ (127,464)
Stockholders' Equity        
Exercise of stock options (in shares) 922 922    
Exercise of stock options $ 4,059 $ 4 4,055  
Repurchase of common stock related to net share settlement (in shares)   (7)    
Repurchase of common stock related to net share settlement (264)   (264)  
Vesting of restricted stock units (in shares)   265    
Vesting of restricted stock units 0 $ 1 (1)  
Stock compensation expense 21,929   21,929  
Net loss $ (70,765)     (70,765)
Stockholders' equity at end of period (in shares) at Dec. 31, 2022 59,190 59,190    
Stockholder's equity at end of period at Dec. 31, 2022 $ 223,636 $ 296 421,569 (198,229)
Stockholders' Equity        
Exercise of stock options (in shares) 312 312    
Exercise of stock options $ 543 $ 2 541  
Repurchase of common stock related to net share settlement (in shares)   (11)    
Repurchase of common stock related to net share settlement (89)   (89)  
Vesting of restricted stock units (in shares)   1,328    
Vesting of restricted stock units 0 $ 7 (7)  
Cancellation of Restricted Stock Awards (in shares)   (13)    
Issuance of Common Stock under ESPP (in shares)   204    
Issuance of Common Stock under ESPP 1,459 $ 1 1,458  
Stock compensation expense 16,936   16,936  
Net loss $ (42,150)     (42,150)
Stockholders' equity at end of period (in shares) at Dec. 31, 2023 61,010 61,010    
Stockholder's equity at end of period at Dec. 31, 2023 $ 200,335 $ 306 $ 440,408 $ (240,379)